Collaboration, Innovation and Enhancing Quality in Clinical Trials
The Global Clinical Trials Connect 2025 will provide a platform to discuss on the futuristic advancements in clinical trials and clinical research. This multidisciplinary program involves broad participation of people from clinical trials community from around the globe who are focused on learning more about clinical research, clinical trials planning and management.
The Pharma and Bio-Tech companies are consistently evolving and new clinical studies, technologies and advancements in care and treatments have augmented the efficiency and at the same time the complexity of clinical trials has increased, with tests being carried out in a highly structured and closely coordinated manner. It is high time that we look into innovative strategies, new technologies, effective and quality collaborations to address these issues, which can cater to the needs of the patient and the industry.
This conference intends to focus on the global health and clinical trials around the world. Bioethics, regulations, patient recruitment, site selection, real-world data, data integration & Strategy, outsourcing, vendor management, quality (QbD) in Trial Conduct, risk-based monitoring, clinical auditing & financial planning and other significant topics that play a key role in clinical trials will be addressed along with innovative sessions on new technologies, effective and quality collaborations.
This program will certainly educate health care scientists on trial design, operations, organizing trials, research computing, regulatory aspects, report on clinical trials and gain a better knowledge of the implications of clinical trials in prevention, diagnosis, clinical trial-related ethics and disease treatments.
The summit will facilitate an invaluable networking opportunities with decision makers and focus on real case studies, insightful presentations and round tables.
Key Highlights
- Patient Recruitment and Site selection
- Innovative trial designs
- Partnership & Collaboration - Sponsors, CROs, Sites and External Vendors
- Patient centric clinical trials
- Making Patient Engagement a Reality
- New innovations in Patient Recruitment planning and execution on a clinical trial
- Outsourcing strategies and models
- Electronic Clinical Outcome Assessment and Electronic Patient Reported Outcome
- Streamlined IRT development process
- Pharmacovigilance & Clinical Trials
- Post-Clinical Trial closed communities
- How to future proof your clinical operations
- Diversity and Inclusion in Clinical Trials
- Implementing Risk Based Monitoring
- Streamlining R&D and lower costs in clinical trials
- Adaptive Trial Model
- Clinical Trial Auditing
- Real World Clinical Trial Strategies
- Data Quality & Technology
- Clinical Data Strategy & Analytics
- Electronic Data Capture (EDC) Systems
- Decentralised Clinical Trials
- Clinical Technology and Driving Innovation
- M-Health, Wearable and Consumer Technology
- Big-Data, IoT and Artificial Intelligence in Clinical trials
- Blockchain technology for improving clinical research quality
The fee includes access to two days of conference sessions, panel discussions, exhibitor access, expert interactions, luxury luncheons, and exclusive networking reception. Post-event, enjoy online presentation access and a certificate of attendance. Enhance your experience with a Networking App Platform offering chat, networking, schedule meeting, and more, for a fully engaging event.
Agenda
Day 1
08:00 Registration & Refreshments
Kick off your conference experience by checking in at our registration desk. Collect your event materials and enjoy a selection of refreshments. It's the perfect time to mingle with fellow attendees and set the tone for an engaging and informative event
08:50 Welcome Address & Chairperson’s opening remarks
Begin your conference journey with a warm welcome from our esteemed Chairperson
Nancy Meyerson-Hess
Chief Compliance and Regulatory Officer
eMQT
Enhancing Efficiency through Streamlined Clinical Trials
09:00 Tactical and Strategic Use of AI in Clinical Trials
The integration of AI in the planning and conduct of clinical trials is gaining significant attention in the biopharmaceutical industry. This keynote presentation will provide a comprehensive exploration of tactical and strategic applications of AI in the design, execution, and analysis and reporting of clinical trials and across the clinical development lifecycle. Moreover, it will highlight the impact of AI on the roles within clinical development, providing insights into the evolving landscape of the industry. This presentation will offer a compelling and thought-provoking perspective of the transformative potential of AI in clinical development.
Richardus Vonk
VP, Head of Oncology Data Analytics and Statistical Sciences
Bayer AG
09:30 Integrating Blockchain into clinical research
Jose Manuel Cervera Grau
Executive Director
Eli Lilly and Company
10:00 Innovating with AI: digital transformations for clinical research
Clinical trials are one of the most expensive parts of the drug development process; thus one of the goals of clinical trial professionals is to increase efficiency along the process. There is a huge amount of excitement around new innovations in AI technology, but it's not always easy to cut through the noise and find out where these innovations can really bring value to clinical research. In this talk, we will provide an overview of some of the latest innovations in AI & NLP (natural language processing), for translation, privacy, and insights, and showcase recent use cases from pharma and healthcare customers.
Jane Reed
Director of Life Sciences NLP
Linguamatics
10:30 Ensuring Compliance and Inspection Readiness Through Effective Risk Management
Miguel Valenzuela
Associate Director Clinical Operations - RBQM+
Alnylam Pharmaceuticals
11:00 Business Card Exchange with Morning Coffee/Tea & Discussion
Network over morning coffee or tea, exchanging business cards or using our app's QR code scanner for easy contact sharing. A prime moment for engaging discussions and new connections
11:20 Forging Successful Global Research Partnership in Southeast Asia - Universiti Malaya Medical Centre's Experience
Prof. Dr. Ho Gwo Fuang
Consultant clinical oncologist
Clinical Investigation Centre, UMMC
11:50 Advancing Patient Safety Through Inclusive Clinical Trials: Harnessing Real-World Data Directly from Source
Martin Gibson
Chief Medical Officer
NorthWest EHealth
12:20 Digital Transformation: Developing and deploying a digital authoring platform across the value chain
Waheed Jowiya
Digitalisation Strategy Lead
Novo Nordisk
Louise Lind Skov
Head of Content Digitalisation
Novo Nordisk
12:45 Luncheon & Networking - Explore, Engage with Your Peers, and Connect at Our Exhibitor Booths
Enjoy a luncheon while networking with peers and exploring exhibitor booths. This is an ideal time to engage with industry leaders, delve into innovative solutions, and forge valuable connections in a collaborative atmosphere.
13:35 Increasing diversity in clinical trials in the UK: Results from a nationally representative survey
Rebecca West
Associate Director leading Global Health
Ipsos
14:00 Patient Involvement and Patient Reported Outcomes. Does it make a difference?
Regine Buffels
Principal Global Medical Affairs Director
Hoffmann-La Roche
14:30 End-to-End management of critical quality factors across a vaccine study/program
Magali Traskine
Associate Director, Central Monitoring
GSK
15:00 From EHR to Sponsor - harnessing electronic health records in clinical research
Rebecca Jackson
Senior Manager, R&D IT, Enabling Innovation
Johnson & Johnson Technology
15:30 Recharge with Tea or Coffee While Networking
Refresh with a tea or coffee break, using this time to continue networking. It's a perfect opportunity to discuss ideas, share experiences, and connect with fellow attendees in a relaxed setting.
15:50 Panel discussion: Critical Success Factors while Planning for Site Selection and Patient Recruitment
Discover sites with a demonstrated track record of good execution in trials.
Study and site staff with solid certifications to expand the likelihood of powerful enrolment and an effective trial.
Factors such as disease prevalence rates, treatment practices, regulatory requirements and statistical considerations must be considered.
Access to subject population with the required eligibility criteria.
Network within industries.
Nancy Meyerson-Hess
Chief Compliance and Regulatory Officer
eMQT
Viraj Rajadhyaksha
Area Medical Director
AstraZeneca
Diane Driver
Head Program Delivery
UCB
Rasmus Hjorth
Head of communication
James Lind Care
16:20 The Role of Investigator-Initiated Trials in Leveraging Real-World Evidence
Viraj Rajadhyaksha
Area Medical Director
AstraZeneca
16:50 Sponsor centric to Patient centric framework - Improving patient recruitment & enhancing their involvement
Lucy Campbell
Research Manager
King's College London
17:20 Panel Discussion: The Future of Patient-Centricity in Clinical Trials - Embedding a patient-centric approach to clinical trial design
How to integrate patient feedback into clinical trial design effectively.
The role of digital health technologies in enhancing patient engagement and experience.
Strategies for maintaining communication and trust with participants throughout the trial.
The impact of patient-centric approaches on trial outcomes and drug development timelines.
Ethical considerations and data privacy in a patient-centered model.
Nancy Meyerson-Hess
Chief Compliance and Regulatory Officer
eMQT
Sophie Wintrich
Patient Advocacy Connector
Patient Co-Next
Diane Driver
Head Program Delivery
UCB
Lukasz Wiech
Chief Medical Officer
European Clinical Trials Information Network
17:50 Interactive Breakout Round Table Discussion
All the participants will have a great opportunity to discuss and explore a selection of most interesting topics discussed during the conference in small groups with their industry colleagues in an informal setting.
Table 1 - Revolutionizing Patient Recruitment: Strategies for Today’s Digital World
Exploring the intersection of digital marketing, social media, and patient advocacy in enhancing recruitment efficiency.
Table 2 - Mastering the Art of Site Selection: Balancing Technology, Geography, and Patient Access
Delving into the criteria and tools that can optimize site selection for diverse and technologically advanced clinical trials.
Table 3 - Harnessing Data Science: The New Frontier in Trial Design and Real-World Evidence
Discussing the transformative potential of big data analytics, AI, and real-world evidence in the design and execution of clinical trials.
Table 4 - The Evolving Landscape of Clinical Trial Regulations: Global Perspectives and Harmonization
Navigating the complexities of international regulatory environments and striving for a harmonized approach to global clinical trials.
Table 5 - Patient-Centricity in Clinical Trials: More Than Just a Buzzword?
Evaluating the real-world application of patient-centric approaches in trial design, conduct, and outcomes.
Table 6 - Innovation in Trial Monitoring and Quality Assurance: Risk-Based Approaches and Beyond
Examining the latest methodologies in risk-based monitoring, quality by design, and the role of clinical auditing in ensuring trial integrity.
18:20 Chairperson’s Closing Remark
End the conference with the Chairperson's closing remarks, summarizing key insights and leaving attendees with final thoughts to inspire ongoing engagement and action.
18:30 Networking Drinks Session - Unwind with Evening Drinks and Engaging Conversations
Wrap up the day with evening drinks and lively conversations. A relaxed setting to network, share insights from the day, and enjoy the company of fellow attendees.
Day 2
08:30 Registration & Refreshments
Start the second day of the conference by checking in and grabbing a morning refreshment. It’s a great opportunity to re-engage with peers, discuss the previous day’s insights, and prepare for another day of learning and networking.
08:50 Welcome Address & Chairperson’s opening remarks
Start the second day with insightful remarks from our Chairperson
Nancy Meyerson-Hess
Chief Compliance and Regulatory Officer
eMQT
Shaping the Future with Innovative Trials
09:00 Personalized Clinical Trials Framework: Considerations for implementation from a patient centricity perspective
Sophie Wintrich
Patient Advocacy Connector
Patient Co-Next
Pauline Frank
Chief Patient Connector
Patient Co-Next
09:30 Roche Rater Academy: An enterprise wide approach to developing a rater training lifecycle to improve rater data quality, productivity and inclusivity for an improved customer experience enabled through a strategic supplier partnership
Aligned Rater certification standards across Roche studies to unlock opportunity to leverage Raters across studies/programs
Enabling multiple qualification pathways tailored to site rater experience
Centralization of rater training and certification process enabling insights to drive decision making
Jennifer Eyerman
Clinical Trial Partner, Clinical Operations, Research and Early Development
Roche
10:00 New opportunities for patient recruitment and diversity - Conducting clinical trials in the MENA region
Rohan Simon
Associate Director - Business Development
Insights Research Organization & Solutions
10:30 Data-Enabled Recruitment to Clinical Trials and How Real-World Data Can Enhance Clinical Trial Outcomes and Safety Monitoring
Tim Williams
Head of Interventional Research - CPRD
Medicines and Healthcare products Regulatory Agency
11:00 Business Card Exchange with Morning Coffee/Tea & Discussion
Network over morning coffee or tea, exchanging business cards or using our app's QR code scanner for easy contact sharing. A prime moment for engaging discussions and new connections.
11:20 Empowering Clinical Research with Artificial Intelligence: Unlocking the Value of Real-World Data
Gabriel Maeztu
Co-Founder & President
IOMED
11:45 Planning and Placement: A recipe for research delivery success
Plan for success. Find out ways to involve patients in your trial design and acquire feedback from KOLs prior to regulatory approvals
Understand how we can work with you to confidently place your research in the right setting and sites in the UK
Karen Matthews
Senior Business Development Manager
NIHR Research Delivery Network
12:15 Smart use of GenAI, NLP and ML in Oncology Clinical Trials
Experience the future of clinical trials with Science4Tech. Delve into the transformative power of GenAI, NLP, and ML as we revolutionize the landscape of oncology research. Experience firsthand how our cutting-edge AI solutions are reshaping the trial process, empowering life science companies to accelerate drug development while slashing both time and costs.
Jordi Guitart
Chief Executive Officer
Science4Tech
12:40 Luncheon & Networking - Explore, Engage with Your Peers, and Connect at Our Exhibitor Booths
Enjoy a luncheon while networking with peers and exploring exhibitor booths. This is an ideal time to engage with industry leaders, delve into innovative solutions, and forge valuable connections in a collaborative atmosphere.
13:30 How clinical trials can utilise predictive ai to simulate a trial to predict its probability of success, and optimise the variables to increase success probability!
Saurabh Jain
Chief Executive Officer
TrialKey
13:55 Quality considerations for the use of Real World Evidence in clinical development
Andrew Gray
Director, QA Clinical Therapeutic Area Head
Johnson & Johnson
14:25 Weighing and evaluating the outsourcing approach that is right for you
Flexible, and easy to implement model.
Creating an effective strategy to decide when to outsource.
Analysing the key risk factors your CRO might bring and how to tackle them.
Craig Elliott
Director Strategic Alliance and Sourcing
Merck Group
14:55 EU PEARL, platform trials
Nadir Ammour
Global Lead, Clinical Innovation & External Partnership
Sanofi
15:25 Recharge with Tea or Coffee While Networking
Refresh with a tea or coffee break, using this time to continue networking. It's a perfect opportunity to discuss ideas, share experiences, and connect with fellow attendees in a relaxed setting.
15:45 Africa’s role in reducing clinical delays
Tina Barton
Chief Operating Officer
Emerging Markets Quality Trials (eMQT)
Shalom Lloyd
Co-Founder & Chief Strategy Officer
Emerging Markets Quality Trials (eMQT)
16:15 Interpretation and Impact of Real-World Clinical Data
Strategies for better decision-making.
High-level models and simulations compelled by data will allow elimination of risky trials.
The potential of real world data in clinical research goes past patient identification and patient recruitment.
Meelis Lootus
Member of IEEE Novel Biomarkers for Decentralised Clinical Trials Working Group
IEEE
16:45 Panel Discussion: Leveraging Big Data and AI in the Era of Tech-Driven Clinical Trials: Opportunities and Ethical Dilemmas
Nancy Meyerson-Hess
Chief Compliance and Regulatory Officer
eMQT
Meelis Lootus
Member of IEEE Novel Biomarkers for Decentralised Clinical Trials Working Group
IEEE
Jennifer Eyerman
Clinical Trial Partner, Clinical Operations, Research and Early Development
Roche
Andrew Gray
Director, QA Clinical Therapeutic Area Head
Johnson & Johnson
Tina Barton
Chief Operating Officer
Emerging Markets Quality Trials (eMQT)
17:15 Partnership & Collaboration - Sponsors, CROs, Sites and External Vendors
Working to create a positive, mutually beneficial environment and relationship between working partners.
Reaping the benefits of strategic collaborations to achieve efficiency, consistency, and reliability.
Achieving preferred providership with a sponsor company.
Dex Bilkic
Director, Alliance Management
AstraZeneca
17:40 Chairperson’s Closing Remark
End the conference with the Chairperson's closing remarks, summarizing key insights and leaving attendees with final thoughts to inspire ongoing engagement and action.
Speakers
Nancy Meyerson-Hess
Chief Compliance and Regulatory Officer
eMQT
Richardus Vonk
VP, Head of Oncology Data Analytics and Statistical Sciences
Bayer AG
Tim Williams
Head of Interventional Research - CPRD
Medicines and Healthcare products Regulatory Agency
Jose Manuel Cervera Grau
Executive Director
Eli Lilly and Company
Dex Bilkic
Director, Alliance Management
AstraZeneca
Prof. Dr. Ho Gwo Fuang
Consultant clinical oncologist
Clinical Investigation Centre, UMMC
Nadir Ammour
Global Lead, Clinical Innovation & External Partnership
Sanofi
Regine Buffels
Principal Global Medical Affairs Director
Hoffmann-La Roche
Meelis Lootus
Member of IEEE Novel Biomarkers for Decentralised Clinical Trials Working Group
IEEE
Jennifer Eyerman
Clinical Trial Partner, Clinical Operations, Research and Early Development
Roche
Craig Elliott
Director Strategic Alliance and Sourcing
Merck Group
Martin Gibson
Chief Medical Officer
NorthWest EHealth
Rebecca West
Associate Director leading Global Health
Ipsos
Viraj Rajadhyaksha
Area Medical Director
AstraZeneca
Andrew Gray
Director, QA Clinical Therapeutic Area Head
Johnson & Johnson
Sophie Wintrich
Patient Advocacy Connector
Patient Co-Next
Tina Barton
Chief Operating Officer
Emerging Markets Quality Trials (eMQT)
Shalom Lloyd
Co-Founder & Chief Strategy Officer
Emerging Markets Quality Trials (eMQT)
Pauline Frank
Chief Patient Connector
Patient Co-Next
Rebecca Jackson
Senior Manager, R&D IT, Enabling Innovation
Johnson & Johnson Technology
Miguel Valenzuela
Associate Director Clinical Operations - RBQM+
Alnylam Pharmaceuticals
Magali Traskine
Associate Director, Central Monitoring
GSK
Gabriel Maeztu
Co-Founder & President
IOMED
Jordi Guitart
Chief Executive Officer
Science4Tech
Saurabh Jain
Chief Executive Officer
TrialKey
Diane Driver
Head Program Delivery
UCB
Karen Matthews
Senior Business Development Manager
NIHR Research Delivery Network
Rasmus Hjorth
Head of communication
James Lind Care
Lukasz Wiech
Chief Medical Officer
European Clinical Trials Information Network
Rohan Simon
Associate Director - Business Development
Insights Research Organization & Solutions
Waheed Jowiya
Digitalisation Strategy Lead
Novo Nordisk
Louise Lind Skov
Head of Content Digitalisation
Novo Nordisk
Jane Reed
Director of Life Sciences NLP
Linguamatics
Lucy Campbell
Research Manager
King's College London
Who Should Attend
This event is designed for senior level attendees from various companies including Pharmaceutical, Bio-Tech, Bio-Pharma, CRO’s, Investigative Sites, Solution provider and Government institutions. Attendees includes VPs, GMs, Directors, Heads and Managers of:
- Clinical Trials
- Clinical Study Management
- Clinical Operations
- Clinical Research
- Patient Organizations
- Patient Recruitment
- Outsourcing
- Vendor Management
- Site Management
- Site Monitoring
- Clinical Pharmacology
- Clinical Data Management
- Risk Monitoring
- EDC
- Clinical/Digital Innovation
- Clinical Design/Protocol design/ Strategy makers
- Clinical Research Sites
- CROs and CMOs
- Hospitals/ Associations
- Regulatory affairs
Location
ADDRESS
London
United Kingdom
Venue to be announced shortly.
